{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:58:29Z","timestamp":1793663909481,"version":"4.5.1"},"reference-count":68,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2019-12369247"],"award-info":[{"award-number":["RF-2019-12369247"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Moyamoya arteriopathy (MA) is a rare cerebrovascular disorder characterized by ischemic\/hemorrhagic strokes. The pathophysiology is unknown. A deregulation of vasculogenic\/angiogenic\/inflammatory pathways has been hypothesized as a possible pathophysiological mechanism. Since lipids are implicated in modulating neo-vascularization\/angiogenesis and inflammation, their deregulation is potentially involved in MA. Our aim is to evaluate angiogenic\/vasculogenic\/inflammatory proteins and lipid profile in plasma of MA patients and control subjects (healthy donors HD or subjects with atherosclerotic cerebrovascular disease ACVD). Angiogenic and inflammatory protein levels were measured by ELISA and a complete lipidomic analysis was performed on plasma by mass spectrometry. ELISA showed a significant decrease for MMP-9 released in plasma of MA. The untargeted lipidomic analysis showed a cumulative depletion of lipid asset in plasma of MA as compared to HD. Specifically, a decrease in membrane complex glycosphingolipids peripherally circulating in MA plasma with respect to HD was observed, likely suggestive of cerebral cellular recruitment. The quantitative targeted approach demonstrated an increase in free sphingoid bases, likely associated with a deregulated angiogenesis. Our findings indicate that lipid signature could play a central role in MA and that a detailed biomarker profile may contribute to untangle the complex, and still obscure, pathogenesis of MA.<\/jats:p>","DOI":"10.3390\/ijms222413410","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T09:34:25Z","timestamp":1639474465000},"page":"13410","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Plasma Lipid Profiling Contributes to Untangle the Complexity of Moyamoya Arteriopathy"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-8558","authenticated-orcid":false,"given":"Michele","family":"Dei Cas","sequence":"first","affiliation":[{"name":"Clinical Biochemistry and Mass Spectrometry Lab, Department of Health Sciences, University of Milan, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-1374","authenticated-orcid":false,"given":"Tatiana","family":"Carrozzini","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-9706","authenticated-orcid":false,"given":"Giuliana","family":"Pollaci","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-6112","authenticated-orcid":false,"given":"Antonella","family":"Potenza","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-8255","authenticated-orcid":false,"given":"Sara","family":"Nava","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-0437","authenticated-orcid":false,"given":"Isabella","family":"Canavero","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tinelli","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8483-3509","authenticated-orcid":false,"given":"Gemma","family":"Gorla","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-9700","authenticated-orcid":false,"given":"Ignazio G.","family":"Vetrano","sequence":"additional","affiliation":[{"name":"Neurosurgical Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Acerbi","sequence":"additional","affiliation":[{"name":"Neurosurgical Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ferroli","sequence":"additional","affiliation":[{"name":"Neurosurgical Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-2923","authenticated-orcid":false,"given":"Elisa F.","family":"Ciceri","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging Department & Interventional Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Esposito","sequence":"additional","affiliation":[{"name":"Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Saletti","sequence":"additional","affiliation":[{"name":"Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7285-123X","authenticated-orcid":false,"given":"Emilio","family":"Ciusani","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-6847","authenticated-orcid":false,"given":"Aida","family":"Zulueta","sequence":"additional","affiliation":[{"name":"Neurorehabilitation Department, IRCCS Istituti Clinici Scientifici Maugeri, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-8860","authenticated-orcid":false,"given":"Rita","family":"Paroni","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry and Mass Spectrometry Lab, Department of Health Sciences, University of Milan, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio A.","family":"Parati","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Ghidoni","sequence":"additional","affiliation":[{"name":"Neurorehabilitation Department, IRCCS Istituti Clinici Scientifici Maugeri, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-628X","authenticated-orcid":false,"given":"Anna","family":"Bersano","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-5031","authenticated-orcid":false,"given":"Laura","family":"Gatti","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and UCV, Neurology IX Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/S0303-8467(97)00082-6","article-title":"Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2019moyamoya\u2019 disease). Research committee on spontaneous occlusion of the circle of willis (moyamoya disease) of the ministry of health and welfare, Japan","volume":"99","author":"Fukui","year":"1997","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000442298","article-title":"Research progresses in understanding the pathophysiology of moyamoya disease","volume":"41","author":"Bersano","year":"2016","journal-title":"Cerebrovasc. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/TACG.S42772","article-title":"Moyamoya disease and syndromes: From genetics to clinical management","volume":"8","author":"Kossorotoff","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3171\/jns.2000.93.6.0976","article-title":"Long-term natural history of hemorrhagic type moyamoya disease in 42 patients","volume":"93","author":"Kobayashi","year":"2000","journal-title":"J. Neurosurg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.513408","article-title":"Moyamoya Disease in Europeans","volume":"39","author":"Kraemer","year":"2008","journal-title":"Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ene.12702","article-title":"Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians","volume":"22","author":"Acker","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3171\/2019.7.JNS191507","article-title":"Racial phenotypes in moyamoya disease: A comparative analysis of clinical presentation and natural history in a single multiethnic cohort of 250 hemispheres","volume":"133","author":"Feghali","year":"2019","journal-title":"J. Neurosurg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2176\/nmc.52.267","article-title":"Review of past research and current concepts on the etiology of moyamoya disease","volume":"52","author":"Houkin","year":"2012","journal-title":"Neurol. Med. Chir."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986732304160204181543","article-title":"Vasculogenic and angiogenic pathways in moyamoya disease","volume":"23","author":"Bedini","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada","year":"2010","journal-title":"J. Hum. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ejhg.2017.92","article-title":"Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians","volume":"25","author":"Guey","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.23736\/S0390-5616.16.03900-X","article-title":"Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West","volume":"64","author":"Raso","year":"2020","journal-title":"J. Neurosurg. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lee, M.J., Fallen, S., Zhou, Y., Baxter, D., Scherler, K., Kuo, M.F., and Wang, K. (2019). The impact of moyamoya disease and RNF213 Mutations on the spectrum of plasma protein and microRNA. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101648"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2020.02.024","article-title":"Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA+ domain-dependent manner","volume":"525","author":"Takeda","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mertens, R., Graupera, M., Gerhardt, H., Bersano, A., Tournier-Lasserve, E., Mensah, M.A., Mundlos, S., and Vajkoczy, P. (2021). The Genetic Basis of Moyamoya Disease. Transl. Stroke Res., 1\u201321.","DOI":"10.1007\/s12975-021-00940-2"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molcel.2019.01.036","article-title":"Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids","volume":"74","author":"Piccolis","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"687088","DOI":"10.3389\/fneur.2021.687088","article-title":"RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability","volume":"12","author":"Mineharu","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ncb3376","article-title":"PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia","volume":"18","author":"Banh","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tinelli, F., Nava, S., Arioli, F., Bedini, G., Scelzo, E., Lisini, D., Farag\u00f2, G., Gioppo, A., Ciceri, E.F., and Acerbi, F. (2020). Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165763"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: Where they are and how they behave","volume":"9","author":"Voelker","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Casares, D., Escrib\u00e1, P.V., and Rossell\u00f3, C.A. (2019). Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092167"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive lipids and chronic inflammation: Managing the fire within","volume":"9","author":"Leuti","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bbalip.2013.07.012","article-title":"Molecular and physiological functions of sphingosine 1-phosphate transporters","volume":"1841","author":"Nishi","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Trostchansky, A., and Rubbo, H. (2019). Bioactive Lipids in Health and Disease, Springer. [1st ed.].","DOI":"10.1007\/978-3-030-11488-6"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MOL.0b013e328082e4d5","article-title":"Membrane lipids as signaling molecules","volume":"18","author":"Fernandis","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_26","first-page":"257","article-title":"The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases","volume":"Volume IX","author":"Honn","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dei Cas, M., Roda, G., Li, F., and Secundo, F. (2020). Functional lipids in autoimmune inflammatory diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093074"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bph.14587","article-title":"Bishop-Bailey, Lipid mediators in immune regulation and resolution","volume":"176","author":"Gilroy","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: Potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-030-21735-8_16","article-title":"Bioactive Lipids in Cancer, Inflammation and Related Diseases, Acute and Chronic Mild Traumatic Brain Injury Differentially Changes Levels of Bioactive Lipids in the CNS Associated with Headache","volume":"1161","author":"Leishman","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_31","first-page":"1871","article-title":"Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice","volume":"119","author":"Camerer","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"ref_33","first-page":"6741518","article-title":"Analytical Strategies in Lipidomics for Discovery of Functional Biomarkers from Human Saliva","volume":"2019","author":"Morton","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1038\/s41598-021-92112-3","article-title":"Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders","volume":"11","author":"Larrea","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cell.2010.11.033","article-title":"Lipidomics: New tools and applications","volume":"143","author":"Wenk","year":"2010","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prostaglandins.2016.12.002","article-title":"Recent advances in lipidomics: Analytical and clinical perspectives","volume":"128\u2013129","author":"Sethi","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10072-018-3664-z","article-title":"GEN-O-MA project: An Italian network studying clinical course and pathogenic pathways of moyamoya disease\u2014Study protocol and preliminary results","volume":"40","author":"Bersano","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e56185","DOI":"10.7554\/eLife.56185","article-title":"Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism","volume":"9","author":"Ahel","year":"2020","journal-title":"eLife"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1096\/fba.2019-00092","article-title":"UBC13 is an RNF213-associated E2 ubiquitin-conjugating enzyme, and Lysine 63-linked ubiquitination by the RNF213-UBC13 axis is responsible for angiogenic activity","volume":"3","author":"Habu","year":"2021","journal-title":"FASEB Bioadv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.devcel.2015.12.015","article-title":"Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT\/Ca(2+)\/NFAT Signaling","volume":"36","author":"Scholz","year":"2016","journal-title":"Dev. Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2176\/nmc.ra.2019-0059","article-title":"Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease","volume":"59","author":"Mikami","year":"2019","journal-title":"Neurol. Med. Chir."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.201712120","article-title":"The AAA+ ATPase\/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets","volume":"218","author":"Sugihara","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lin, R., Xie, Z., Zhang, J., Xu, H., Su, H., Tan, X., Tian, D., and Su, M. (2012). Clinical and immunopathological features of Moyamoya disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036386"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/mus.21737","article-title":"MMP-9 overexpression improves myogenic cell migration and engraftment","volume":"42","author":"Morgan","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"721118","DOI":"10.3389\/fneur.2021.721118","article-title":"MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1177\/0271678X18768443","article-title":"Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease","volume":"38","author":"Prinz","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","article-title":"Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease","volume":"81","author":"Kang","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","article-title":"Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease","volume":"72","author":"Fujimura","year":"2009","journal-title":"Surg. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9792412","DOI":"10.1155\/2019\/9792412","article-title":"Serum Uric Acid and Triglycerides in Chinese Patients with Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study","volume":"2019","author":"Ma","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Inokuchi, J.I., Kanoh, H., Inamori, K.I., Nagafuku, M., Nitta, T., and Fukase, K. (2021). Homeostatic and pathogenic roles of the GM3 ganglioside. FEBS J.","DOI":"10.1111\/febs.16076"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3389\/fimmu.2020.01305","article-title":"Sulfatide Inhibits HMGB1 Secretion by Hindering Toll-Like Receptor 4 Localization Within Lipid Rafts","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3171\/2017.5.JNS17147","article-title":"Mitochondrial abnormalities related to the dysfunction of circulating endothelial colony-forming cells in moyamoya disease","volume":"129","author":"Choi","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1161\/STROKEAHA.120.032297","article-title":"Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells","volume":"52","author":"Wang","year":"2021","journal-title":"Stroke"},{"key":"ref_56","first-page":"e21287","article-title":"Ceramide synthase 2-C24:1 -ceramide axis limits the metastatic potential of ovarian cancer cells","volume":"35","author":"Zhang","year":"2021","journal-title":"FASEB J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2020.09.030","article-title":"Why and how increased plasma ceramides predict future cardiovascular events?","volume":"314","author":"Jauhiainen","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yexcr.2015.02.025","article-title":"Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy","volume":"333","author":"Newton","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1161\/STROKEAHA.120.030027","article-title":"Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study","volume":"51","author":"Ge","year":"2020","journal-title":"Stroke"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/neuros\/nyaa284","article-title":"Clinical Course of Unilateral Moyamoya Disease","volume":"87","author":"Church","year":"2020","journal-title":"Neurosurgery"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1161\/STROKEAHA.120.030653","article-title":"Association Between the Onset Pattern of Adult Moyamoya Disease and Risk Factors for Stroke","volume":"51","author":"Hirano","year":"2020","journal-title":"Stroke"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis (2012). Health labour sciences research grant for research on measures for intractable diseases guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of willis). Neurol. Med. Chir., 52, 245\u2013266.","DOI":"10.2176\/nmc.52.245"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/hr.2011.68","article-title":"Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy","volume":"34","author":"Lee","year":"2011","journal-title":"Hypertens. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mvr.2010.05.003","article-title":"HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects","volume":"80","author":"Rossi","year":"2010","journal-title":"Microvasc. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","article-title":"Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus","volume":"45","author":"Fadini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1007\/s00125-007-0732-y","article-title":"Glucose tolerance is negatively associated with circulating progenitor cell levels","volume":"50","author":"Fadini","year":"2007","journal-title":"Diabetologia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \u201cmoyamoya\u201d disease","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Dei Cas, M., Zulueta, A., Mingione, A., Caretti, A., Ghidoni, R., Signorelli, P., and Paroni, R. (2020). An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line. Cells, 9.","DOI":"10.3390\/cells9051197"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/24\/13410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:47:23Z","timestamp":1760168843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/24\/13410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":68,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222413410"],"URL":"https:\/\/doi.org\/10.3390\/ijms222413410","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]}}}